Cytori Therapeutics, Inc. (USA) (NASDAQ:CYTX)

CAPS Rating: 1 out of 5

A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions.

Recs

0
Player Avatar bIlluminati (31.15) Submitted: 7/18/2012 12:42:10 AM : Underperform Start Price: $2.78 CYTX Score: +9.89

Cash flowing out.

Featured Broker Partners


Advertisement